GALM
Basic information
Region (hg38): 2:38666081-38741237
Links
Phenotypes
GenCC
Source:
- galactosemia 4 (Moderate), mode of inheritance: AR
- galactosemia 4 (Strong), mode of inheritance: AR
- galactosemia 4 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Galactosemia IV | AR | Biochemical | Dietary management (with a galactose-free diet) has been reported as resulting in normal galactose levels; some have been reported as resuming a normal diet in childhood and maintaining normal galactose levels | Biochemical; Ophthalmologic | 30451973; 30910422 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- Galactosemia 4 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GALM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 13 | ||||
missense | 29 | 34 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 16 | 16 | ||||
Total | 3 | 0 | 32 | 13 | 21 |
Highest pathogenic variant AF is 0.0000526
Variants in GALM
This is a list of pathogenic ClinVar variants found in the GALM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-38666166-C-T | Inborn genetic diseases | Likely benign (Jan 31, 2024) | ||
2-38666169-C-T | Inborn genetic diseases | Uncertain significance (Nov 17, 2022) | ||
2-38666174-A-G | Inborn genetic diseases | Uncertain significance (Dec 13, 2021) | ||
2-38666174-A-T | Uncertain significance (Oct 17, 2022) | |||
2-38666183-G-A | Uncertain significance (Aug 14, 2021) | |||
2-38666190-G-C | Uncertain significance (Oct 13, 2022) | |||
2-38666196-T-C | Uncertain significance (Oct 05, 2022) | |||
2-38666197-G-A | Likely benign (Nov 21, 2023) | |||
2-38666223-A-G | GALM-related disorder | Uncertain significance (May 26, 2024) | ||
2-38666238-C-T | Inborn genetic diseases | Uncertain significance (Apr 08, 2024) | ||
2-38666255-G-T | Inborn genetic diseases | Uncertain significance (Feb 01, 2023) | ||
2-38666258-A-G | Inborn genetic diseases | Uncertain significance (Dec 03, 2024) | ||
2-38666274-G-A | Inborn genetic diseases | Uncertain significance (Oct 04, 2022) | ||
2-38666283-C-T | Uncertain significance (Nov 24, 2022) | |||
2-38666308-G-A | GALM-related disorder | Benign (Jan 26, 2024) | ||
2-38666311-G-A | Likely benign (Dec 30, 2023) | |||
2-38666325-T-C | Inborn genetic diseases | Uncertain significance (Oct 27, 2021) | ||
2-38666335-C-A | Likely benign (Dec 13, 2023) | |||
2-38666518-A-G | Benign (May 12, 2021) | |||
2-38666535-G-A | Benign (May 12, 2021) | |||
2-38675784-T-C | Benign (May 12, 2021) | |||
2-38675812-G-T | Benign (May 25, 2021) | |||
2-38675880-T-A | Benign (May 13, 2021) | |||
2-38675909-C-G | Uncertain significance (Apr 10, 2023) | |||
2-38675916-C-A | Pathogenic (Feb 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GALM | protein_coding | protein_coding | ENST00000272252 | 7 | 75328 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.88e-11 | 0.0581 | 125578 | 0 | 170 | 125748 | 0.000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.146 | 194 | 188 | 1.03 | 0.00000979 | 2201 |
Missense in Polyphen | 74 | 82.866 | 0.89301 | 947 | ||
Synonymous | -0.826 | 89 | 79.6 | 1.12 | 0.00000442 | 694 |
Loss of Function | 0.0512 | 16 | 16.2 | 0.986 | 7.73e-7 | 192 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000852 | 0.000852 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000924 | 0.000925 |
Finnish | 0.00286 | 0.00282 |
European (Non-Finnish) | 0.000535 | 0.000528 |
Middle Eastern | 0.000924 | 0.000925 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000494 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Mutarotase converts alpha-aldose to the beta-anomer. It is active on D-glucose, L-arabinose, D-xylose, D-galactose, maltose and lactose (By similarity). {ECO:0000250, ECO:0000269|PubMed:12753898, ECO:0000269|PubMed:15026423}.;
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Glycolysis;Glycogenosis, Type VII. Tarui disease;Gluconeogenesis;Glycogenosis, Type IA. Von gierke disease;Glycogenosis, Type IC;Fanconi-bickel syndrome;Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease;Triosephosphate isomerase;Fructose-1,6-diphosphatase deficiency;Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1);Glycogenosis, Type IB;NOTCH-Ncore;D-galactose degradation V (Leloir pathway);trehalose degradation;sucrose degradation
(Consensus)
Recessive Scores
- pRec
- 0.189
Intolerance Scores
- loftool
- 0.826
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.54
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.429
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.976
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Galm
- Phenotype
Gene ontology
- Biological process
- glucose metabolic process;galactose metabolic process;galactose catabolic process via UDP-galactose
- Cellular component
- cytoplasm;extracellular exosome
- Molecular function
- aldose 1-epimerase activity;carbohydrate binding